References
- Pellicer A, Albert C, Mercader A et al. The pathogenesis of ovarian hyperstimulation syndrome: in vivo studies investigating the role of interleukin-1β, interleukin-6, and vascular endothelial growth factor. Fertil. Steril.71, 482–489 (1999).
- Wunder DM, Kretschmer R, Bersinger NA. Concentrations of leptin and C-reactive protein in serum and follicular fluid during assisted reproductive cycles. Hum. Reprod.20, 1266–1271 (2005).
- Liberatori S, Bini L, De Felice C et al. A two-dimensional protein map of human amniotic fluid at 17 weeks’ gestation. Electrophoresis18, 2816–2822 (1997).
- Park SJ, Yoon WG, Song JS et al. Proteome analysis of human amnion and amniotic fluid by two-dimensional electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Proteomics6, 349–363 (2006).
- Tsangaris GT, Kolialexi A, Karamessinis PM et al. The normal human amniotic fluid supernatant proteome. In Vivo20, 479–490 (2006).
- Nagalla SR, Canick JA, Jacob T et al. Proteomic analysis of maternal serum in Down syndrome: identification of novel protein biomarkers. J. Proteome Res.6, 1245–1257 (2007).
- Nilsson S, Ramström M, Palmblad M et al. Explorative study of the protein composition of amniotic fluid by liquid chromatography electro-spray ionization Fourier transform ion cyclotron resonance mass spectrometry. J. Proteome Res.3, 884–889 (2004).
- Michel PE, Crettaz D, Morier P et al. Proteome analysis of human plasma and amniotic fluid by off-gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis27, 1169–1181 (2006)
- Queloz PA, Crettaz D, Thadikkaran L et al. Proteomic analyses of amniotic fluid: potential applications in health and diseases. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci.850, 336–342 (2006).
- Michaels JE, Dasari S, Pereira L et al. Comprehensive proteomic analysis of the human amniotic fluid proteome: gestational age-dependent changes. J. Prot. Res.6, 1277–1285 (2007).
- Cho CK, Shan SJ, Winsor EJ, Diamandis EP. Proteomics analysis of human amniotic fluid. Mol. Cell. Proteomics6, 1406–1415 (2007).
- Tsangaris G, Weitzdörfer R, Pollak D et al. The amniotic fluid cell proteome. Electrophoresis26, 1168–1173 (2005).
- Oh JE, Fountoulakis M, Juranville JF et al. Proteomic determination of metabolic enzymes of the amnion cell: basis for a possible diagnostic tool? Proteomics4, 1145–1158 (2004).
- Wang TH, Chang YL, Peng HH et al. Rapid detection of fetal aneuploidy using proteomics approaches on amniotic fluid supernatant. Prenat. Diagn.25, 559–566 (2005).
- Tsangaris GT, Karamessinis P, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Down syndrome. Proteomics6, 4410–4419 (2006).
- Mavrou A, Anagnostopoulos AK, Kolialexi A et al. Proteomic analysis of amniotic fluid in pregnancies with Turner syndrome fetuses. J. Proteome Res.7, 1862–1866 (2008).
- Wang TH, Chao AS, Chen JK et al. Network analyses of differentially expressed proteins in amniotic fluid supernatant associated with abnormal human karyotypes. Fertil. Steril. DOI: 10.1016/j.fertnstert.2008.05.038 (2008) (Epub ahead of print).
- Kolialexi A, Tsangaris GT, Papantoniou N et al. Application of proteomics for the identification of differentially expressed protein markers for Down syndrome in maternal plasma. Prenat. Diagn.28, 691–698 (2008).